Ovarian Cancer Study Suffers Big Setback
ImmunoGen shares dropped on Monday after the firm released data from its late-stage ovarian cancer study at the European Society for Medical Oncology (ESMO) 2019 Congress in Barcelona, Spain.
All Work
Chris Lange
Are Dova Pharma Investors Getting the Most Out of This Acquisition?
Dova Pharmaceuticals shares jumped on Monday after the firm announced that it would be acquired by Swedish Orphan Biovitrum, or Sobi. But are Dova investors getting enough out of this acquisition?
Bed Bath & Beyond, Constellation Brands, Costco, PepsiCo and More Earnings Coming This Week
24/7 Wall St. has put together a preview of Costco, PepsiCo and some of the other most prominent earnings reports expected this week.
Was Peloton the Final Straw for the IPO Market?
A horde of companies have come public this year expecting the best, but even with strong market tailwinds many of these firms have fallen to the wayside. Peloton was the most recent company to…
Why Analysts Like Micron Despite the Big Drop After Earnings and Guidance
Although Micron Technology investors sent shares much lower after it released fiscal fourth-quarter financial results, analysts remain cautiously positive on the stock.
Good News for Teens Suffering Atopic Dermatitis
Pfizer has announced positive top-line results from a second Phase 3 pivotal study evaluating abrocitinib, in patients aged 12 and older with moderate to severe atopic dermatitis.
Why Micron Earnings Aren’t Enough
Micron Technology released better than expected fiscal fourth-quarter financial results after markets closed Thursday.
Why One Analyst Sees China As a Huge Overhang For Tech in Q3
Third quarter earnings season is coming soon for tech players, and this will take place over the next month. However, the biggest worry from investors continues to be the China black cloud which is…
Will the Markets Stay On Track in 2020?
Although 2019 is not over yet, one analyst is already making forecasts on what we have in store for 2020.
Peloton’s Underwhelming IPO
Interactive fitness platform Peloton had an inauspicious start to trading on Thursday in its initial public offering.
Is This the Beginning of a Big Beyond Meat Partnership With McDonald’s?
Beyond Meat shares jumped on Thursday after it was announced that McDonald’s will be testing a new plant, lettuce and tomato (PLT) sandwich using Beyond Meat's patties in some restaurants in Canada next week.
What to Watch When Micron Reports After the Close
Micron is set to release its most recent financial results after the markets close on Thursday, and Wall Street expectations are low.
Is This Trial Really Disappointing News for Non-Alcoholic Steatohepatitis Sufferers?
Enanta Pharma shares dropped on Thursday after the company announced topline results from its Argon-1 Phase 2a study of EDP-305 for the treatment of non-alcoholic steatohepatitis (NASH).
Conagra Takes a Bite Out of Earnings
Conagra shares got a boost after it released mixed fiscal first-quarter financial results early on Thursday.
Q2 GDP Stays In Line
The Bureau of Economic Analysis reported on Thursday that the domestic economy grew at a rate of 2.0% (annual) in the second quarter of 2019.
Why Analysts Are Growing Incredibly Optimistic on Nike After Earnings
After Nike released fiscal first-quarter financial results, investors and analysts alike chased shares to all-time highs.
What to Watch When Micron Reports Thursday
Micron Technology is scheduled to report its fiscal first-quarter financial results after the markets close on Thursday.
Altria’s Plans Go Up in Smoke
Altria and Philip Morris saw their shares moving in opposite directions after the companies announced that their merger discussions have ended.
Achillion Pharma Wins Big With FDA Breakthrough
Achillion Pharma shares jumped on Wednesday after the firm announced that the FDA has granted Breakthrough Therapy designation for danicopan (ACH-4471).
What to Expect When Conagra Reports Thursday Morning
Conagra Brands is set to release its fiscal first-quarter earnings report before the markets open on Thursday. How will its restructuring affect the results?